Efficacy of Positron Emission Mammography in evaluating clinical response after preoperative chemotherapy

Efficacy of Positron Emission Mammography in evaluating clinical response after preoperative chemotherapy - Efficacy of Positron Emission Mammography in evaluating clinical responce after preoperative chemotherapy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027374

Enrollment

Registered

2017-05-17

Start date

2017-03-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

PEM

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Early breast cancer patients receiving preoperative chemotherapy

Exclusion criteria

Exclusion criteria: Allergy with FDG Patients holding pacemaker Patients with pregnancy or breastfeeding Patients with diabetes Patients with difficult of taking PEM

Design outcomes

Primary

Measure	Time frame
Sensitivity(pCR(pT0))	—

Secondary

Measure	Time frame
Specificity Positive predictive value Negative predictive value Accuracy Relation between the point of SUV and pCR	—

Countries

Japan

Contacts

Public ContactMadoka Iwase

Aichi Cancer Center Breast Oncology

miwase@aichi-cc.jp052-762-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026